Correction: Evaluation of endoscopic submucosal dissection as a treatment option for duodenal tumors ≥ 20 mm: a systematic review and meta-analysis by lesion size - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction: Assessment of Endoscopic Submucosal Dissection for Treating Duodenal Tumors ≥ 20 mm: A Systematic Review and Meta-Analysis Based on Lesion Size

  • By

  • Daisuke Minezaki

  • Yusaku Takatori

  • Motohiko Kato

  • Yasunori Sato

  • Kohei Takizawa

  • Koichi Kurahara

  • Naomi Kakushima

  • Nobutsugu Abe

  • Osamu Dohi

  • Satoru Nonaka

  • Seiichiro Fukuhara

  • Shoichi Yoshimizu

  • Shu Hoteya

  • Yasushi Yamasaki

  • Naohisa Yahagi

  • September 30, 2026

Share

Clinical Scorecard: Correction: Assessment of Endoscopic Submucosal Dissection for Treating Duodenal Tumors ≥ 20 mm: A Systematic Review and Meta-Analysis Based on Lesion Size

At a Glance

CategoryDetail
ConditionDuodenal Tumors
Key MechanismsEndoscopic Submucosal Dissection
Target PopulationPatients with duodenal tumors ≥ 20 mm
Care SettingGastroenterology

Key Highlights

  • Correction of enrollment period for Inoue et al. (2014) from 2004–2019 to 1993–2011
  • Figure 1 published incorrectly and has been corrected
  • Supplementary files 1, 2, 3, 4, and 8 replaced with correct versions

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          Not specified

          Not specified

          Clinical Best Practices

            Related Resources & Content

            Original Source(s)

            Related Content